… 25% of beta-2 receptors are blocked) eg Labetalol (but problems with postural hypotension
and skin … drugs amlodipine/perindopril both of which have long plasma half-lives over 30 h. …

… , betablockers are an important class of cardiovascular drugs, reducing the mortality and
morbidity rates in patients with … Studies on this topic have demonstrated that beta-blockers are …

… -blockers in HFrEF patients with the most common comorbidities. In particular, we will discuss
the role and most appropriate beta-blocker in patients with … Non-selective beta blockers, in …

… Beta-blockers are widely used in the treatment of hypertension. Beta-blockers include a
diverse group of drugs … In conclusion, atenolol should not be used as an antihypertensive drug. …

… data record supply of medication to patients (one … patients with GP prescriptions for
topical beta-blockers in 2003 and classified patients according to whether a systemic beta-blocker …

… class, it may be possible to determine whether and which tolerability issues are indeed a
class effect of β-blockers or whether these agents should be evaluated on a case-by-case basis…

… activity are preferred until future studies resolve this issue. … of these medications and will
ensure that these patients are not … It may be necessary to discontinue the drug in few patients …

… For each study patient, we determined the use of heart failure medications between April 1…
beta-blockers with intrinsic sympathomimetic activity, we excluded patients taking these drugs …

… Beta-adrenergic blocking drugs or beta-blockers (BB) have morbidity and mortality benefits
in the management of patients with … This raises an important issue about the care of patients …

… However, by controlling adrenergic drive and reducing the heart rate, beta-blockers
could reduce the risk of arrhythmias and sudden death among COPD patients. Thus, beta-blocker …